|
||||||||||||||||
HUM-MOLGEN -> Events -> Meetings and Conferences | ||||||||||||||||
Good Governance: Risk Management in a High Risk Industry | ||||||||||||||||
July 05, 2002 | ||||||||||||||||
Biotechnology Investment Today, New York 24 July 2002 12.00 –1.00 Registration & Lunch 1.00 – 1.20 Wall Street Briefing Why is good governance in biotech important to the markets? 1.20 - 1.40 Business Briefing Introduction to Corporate Risk Management 1.40 – 2.50 Panel: Long Range Planning Against Financial Risk Balancing short term survival against long term goals – stable corporate financing throughout the business cycle Managing communication and investor relations – planning for disclosure and due diligence Strategic insurance planning for biotech companies 2.50 – 3.10 Breakout 3.10 – 4.20 Panel: Preparing for Legal, Regulatory and Technical Risks Corporate strategy for effective IP management, technology transfer and licensing in biotech companies Avoiding risk and maximising return in partnerships – how to undertake and survive due diligence Building successful R & D partnerships Clinical Trial Liability Risk Management 420 – 4.40 Breakout 4.40 – 5.50 Panel: Building Strong Corporate Defences Against Risk Corporate structuring – acting early to protect shareholder value Creating a management structure for long-term growth and stability Corporate and personal liability risks and how to insure against them 5.50 - 6.00 Wrap-up Paul Wake, Editor-in-Chief, Biotechnology Investment Today 6.00 – 8.30 Investor Network Reception |
||||||||||||||||
Organized by: | Biotechnology Investment Today | |||||||||||||||
Invited Speakers: | Dan D'Agostino, Managing Director, Punk Ziegal & Company Julian Fisher, Director & Managing Consultant, Reuters Business Consulting Ellen Corenswet, Partner, Brobeck, Phleger & Harrison LLP Anthony Santoro, VP, American International Group Nigel Howard, Partner, Brobeck, Phleger & Harrison LLC Theodore Roumel, Deputy Director of Technology Transfer, National Institutes of Health Robert Cook, CFO, Pharmos Corporation Gene Mancino, President, Blau Mancino Associates Lisa Boutera, VP, American International Group |
|||||||||||||||
Deadline for Abstracts: | 19 July 2002 | |||||||||||||||
Registration: | Registration is open to CEOs and Directors of biotech and pharmaceutical companies | |||||||||||||||
E-mail: | rowan@investinbiotech.com | |||||||||||||||
Posted by: | Paul Wake, Editor in Chief, Biotechnology Investment Today | |||||||||||||||
Host: | host213-123-223-73.in-addr.btopenworld.com | |||||||||||||||
|
||||||||||||||||
Generated by meetings and positions 5.0 by Kai Garlipp |